Related Experiment Video
Updated: Feb 27, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Allosteric sensitization of proapoptotic BAX
Jonathan R Pritz1, Franziska Wachter1, Susan Lee1
1Department of Pediatric Oncology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
Abstract:
BCL-2-associated X protein (BAX) is a critical apoptotic regulator that can be transformed from a cytosolic monomer into a lethal mitochondrial oligomer, yet drug strategies to modulate it are underdeveloped due to longstanding difficulties in conducting screens on this aggregation-prone protein. Here, we overcame prior challenges and performed an NMR-based fragment screen of full-length human BAX. We identified a compound that sensitizes BAX activation by binding to a pocket formed by the junction of the α3-α4 and α5-α6 hairpins. Biochemical and structural analyses revealed that the molecule sensitizes BAX by allosterically mobilizing the α1-α2 loop and BAX BH3 helix, two motifs implicated in the activation and oligomerization of BAX, respectively. By engaging a region of core hydrophobic interactions that otherwise preserve the BAX inactive state, the identified compound reveals fundamental mechanisms for conformational regulation of BAX and provides a new opportunity to reduce the apoptotic threshold for potential therapeutic benefit.
Insights
Researchers identified a novel compound that modulates BCL-2-associated X protein (BAX) activity. This discovery offers a new therapeutic strategy by lowering the apoptotic threshold, addressing challenges in BAX-targeted drug development.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- BCL-2-associated X protein (BAX) is a key regulator of apoptosis.
- BAX transitions from a cytosolic monomer to a mitochondrial oligomer.
- Developing drugs targeting BAX is challenging due to its aggregation-prone nature.
Purpose of the Study:
- To overcome challenges in screening BAX and identify modulators.
- To understand the mechanism of BAX activation and oligomerization.
- To explore therapeutic strategies for modulating BAX activity.
Main Methods:
- Performed an NMR-based fragment screen of full-length human BAX.
- Conducted biochemical and structural analyses of identified compounds.
- Investigated the allosteric effects of the compound on BAX conformation.
Main Results:
- Identified a compound that sensitizes BAX activation.
- The compound binds to a pocket at the junction of α3-α4 and α5-α6 hairpins.
- The compound allosterically mobilizes the α1-α2 loop and BAX BH3 helix, key to BAX activation and oligomerization.
Conclusions:
- The identified compound reveals fundamental mechanisms of BAX conformational regulation.
- The compound engages hydrophobic interactions preserving the inactive BAX state.
- This provides a new opportunity to reduce the apoptotic threshold for therapeutic benefit.
More Related Videos
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
08:47Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Apoptosis
Caspases
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...